4.1 Article

Radiation protection of human lymphocyte chromosomes in vitro by orientin and vicenin

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S1383-5718(01)00263-7

Keywords

orientin; vicenin; Ocimum flavonoids; MN assay; chromosome protection

Ask authors/readers for more resources

Orientin (Ot) and Vicenin (Vc), two water-soluble flavonoids isolated from the leaves of Indian holy basil Ocimum sanctum have shown significant protection against radiation lethality and chromosomal aberrations in vivo. In the present study the protective effect of Ot and Vc against radiation induced chromosome damage in cultured human peripheral lymphocytes was determined by micronucleus test. In order to select the most effective drug concentration, fresh whole blood was exposed to 4 Gy of cobalt-60 gamma -radiation with or without a 30 min pre-treatment with 6.25, 12.5, 15.0, 17.5 or 20 muM of Ot/Vc. Micronucleus (MN) assay was done by cytochalasin induced cytokinesis block method. Radiation significantly increased the MN frequency (16 times normal). Pre-treatment with either Ot or Vc at all concentrations significantly (P < 0.05-0.001) reduced the MN count in a concentration dependent manner, with the optimum effect at 17.5 muM. Therefore, fresh blood samples were incubated with/without 17.5 RM Ot/Vc for 30 min and then exposed to 0.5-4 Gy of gamma -radiation. Radiation increased the MN frequency linearly (r(2) = 0.99) with dose. Pre-treatment with Ot or Vc significantly (P < 0.01-0.001) reduced the MN counts to 51-67% of RT alone values, giving DMFs of 2.62 (Ot) and 2.48 (Vc). Both the compounds showed significant antioxidant activity in vitro at the above concentrations, which was significantly higher than that of DMSO at equimolar concentrations. Thus, the results demonstrate that both the flavonoids give significant protection to the human lymphocytes against the clastogenic effect of radiation at low, non-toxic concentrations. The radioprotection seems to be associated with their antioxidant activity. The clinical potential of these protectors in cancer therapy needs to be investigated. (C) 2001 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available